Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice

被引:49
作者
Vasquez, AC
Feili-Hariri, M
Tan, RJ
Morel, PA
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA
关键词
APC; diabetes; cytokines; Flt3; ligand;
D O I
10.1111/j.1365-2249.2003.02359.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The phenotype and function of splenic DC populations from diabetes-prone NOD mice were chara-cterized and compared to DC from diabetes-resistant strains in the presence or absence of Flt3 ligand (FL) treatment. NOD mice were found to have significantly fewer CD8alpha(+) DC than both B10.BR and C57BL/6 mice, and this defect was reversed by FL treatment. Freshly isolated CD8alpha(+) and CD8alpha(-) DC from all three strains were found to express similar levels of costimulatory molecules and this was similar in both FL-treated and untreated animals. IL-12 p40 production was significantly lower in purified CD11c(+) DC from NOD mice compared to DC from C57BL/6 or B10.BR mice. CD8alpha(+) DC isolated from NOD mice produced lower levels of IL-12p40 than CD8alpha(+) DC from C57CBL/6 and this was dependent on the nature of the stimulus given. In contrast both CD8alpha(+) and CD8alpha(-) DC from FL-treated mice produced high levels of IL-12p40 following activation, but only the CD8alpha(-) DC produced IL-12p70. Functionally, freshly isolated CD8alpha(-) DC were more stimulatory than CD8alpha(+) DC in a primary allogeneic mixed lymphocyte reaction. However, DC maturation resulted in increased T cell stimulatory capacity for both DC subsets, and this pattern was seen in all strains. These results demonstrate significant differences in phenotype and function of splenic NOD CD8alpha(+) DC, and further suggest that FL treatment may reverse some of these abnormalities.
引用
收藏
页码:209 / 218
页数:10
相关论文
共 49 条
[1]   Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains -: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice [J].
Alleva, DG ;
Pavlovich, RP ;
Grant, C ;
Kaser, SB ;
Beller, DI .
DIABETES, 2000, 49 (07) :1106-1115
[2]   Tolerance to islet autoantigens in type 1 diabetes [J].
Bach, JF ;
Chatenoud, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :131-161
[3]   MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions [J].
Bedford, P ;
Garner, K ;
Knight, SC .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (11) :1739-1744
[4]  
Boudaly S, 2002, EUR CYTOKINE NETW, V13, P29
[5]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[6]   Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation [J].
Dahlén, E ;
Hedlund, G ;
Dawe, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2444-2456
[7]   Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-CSF [J].
Daro, E ;
Butz, E ;
Smith, J ;
Teepe, M ;
Maliszewski, CR ;
McKenna, HJ .
CYTOKINE, 2002, 17 (03) :119-130
[8]  
De Smedt T, 2001, J LEUKOCYTE BIOL, V69, P951
[9]   CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo [J].
den Haan, JMM ;
Lehar, SM ;
Bevan, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1685-1695
[10]   Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis [J].
Feili-Hariri, M ;
Falkner, DH ;
Gambotto, A ;
Papworth, GD ;
Watkins, SC ;
Robbins, PD ;
Morel, PA .
HUMAN GENE THERAPY, 2003, 14 (01) :13-23